BeiGene, Ltd. (BGNE)
USD 184.71
(0.49%)
USD 184.71
(0.49%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.12 Billion USD | 37.39% |
| 2022 | -1.72 Billion USD | -24.4% |
| 2021 | -1.39 Billion USD | 13.21% |
| 2020 | -1.62 Billion USD | -72.85% |
| 2019 | -941.27 Million USD | -41.14% |
| 2018 | -695.38 Million USD | -688.71% |
| 2017 | -93.69 Million USD | 26.56% |
| 2016 | -115.15 Million USD | -115.83% |
| 2015 | -55.2 Million USD | -312.54% |
| 2014 | -14.2 Million USD | -379.4% |
| 2013 | -3.14 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -261.34 Million USD | 34.45% |
| 2024 Q2 | -82.23 Million USD | 65.34% |
| 2023 Q3 | -133.96 Million USD | 54.8% |
| 2023 Q4 | -359.97 Million USD | -168.7% |
| 2023 FY | - USD | 37.39% |
| 2023 Q1 | -371.25 Million USD | 20.74% |
| 2023 Q2 | -296.38 Million USD | 20.17% |
| 2022 FY | - USD | -24.4% |
| 2022 Q2 | -439.21 Million USD | 0.88% |
| 2022 Q1 | -443.09 Million USD | 24.47% |
| 2022 Q4 | -468.43 Million USD | -10.96% |
| 2022 Q3 | -422.15 Million USD | 3.88% |
| 2021 Q3 | -420.9 Million USD | 10.26% |
| 2021 Q4 | -586.61 Million USD | -39.37% |
| 2021 FY | - USD | 13.21% |
| 2021 Q1 | 71.49 Million USD | 115.08% |
| 2021 Q2 | -469.04 Million USD | -756.03% |
| 2020 Q3 | -425.3 Million USD | -29.35% |
| 2020 Q4 | -474.24 Million USD | -11.51% |
| 2020 FY | - USD | -72.85% |
| 2020 Q2 | -328.81 Million USD | 7.23% |
| 2020 Q1 | -354.43 Million USD | 4.98% |
| 2019 FY | - USD | -41.14% |
| 2019 Q4 | -373.01 Million USD | -21.68% |
| 2019 Q1 | -163.7 Million USD | 40.13% |
| 2019 Q2 | -79.74 Million USD | 51.29% |
| 2019 Q3 | -306.55 Million USD | -284.41% |
| 2018 Q2 | -157.91 Million USD | -49.31% |
| 2018 Q1 | -105.76 Million USD | -14.52% |
| 2018 FY | - USD | -688.71% |
| 2018 Q4 | -273.43 Million USD | -92.48% |
| 2018 Q3 | -142.05 Million USD | 10.04% |
| 2017 FY | - USD | 26.56% |
| 2017 Q2 | -57.48 Million USD | -13.41% |
| 2017 Q3 | 115.62 Million USD | 301.14% |
| 2017 Q4 | -92.35 Million USD | -179.87% |
| 2017 Q1 | -50.68 Million USD | -35.61% |
| 2016 Q1 | -21.31 Million USD | 19.4% |
| 2016 Q4 | -37.37 Million USD | -8.52% |
| 2016 Q3 | -34.44 Million USD | -47.46% |
| 2016 Q2 | -23.35 Million USD | -9.58% |
| 2016 FY | - USD | -115.83% |
| 2015 FY | - USD | -312.54% |
| 2015 Q2 | -4.99 Million USD | 47.93% |
| 2015 Q1 | -9.59 Million USD | -212.99% |
| 2015 Q3 | -13.29 Million USD | -166.21% |
| 2015 Q4 | -26.44 Million USD | -98.86% |
| 2014 Q3 | -7.85 Million USD | -461.67% |
| 2014 Q4 | -3.06 Million USD | 60.98% |
| 2014 FY | - USD | -379.4% |
| 2014 Q1 | -1.39 Million USD | 0.0% |
| 2014 Q2 | -1.39 Million USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | -6.86 Million USD | -16274.651% |
| Jaguar Health, Inc. | -33.13 Million USD | -3294.437% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -639.015% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -1881.554% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -335.487% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 1205.519% |
| ContextLogic Inc. | -324 Million USD | -247.102% |
| MiMedx Group, Inc. | 40.51 Million USD | 2875.652% |
| MEI Pharma, Inc. | 26.38 Million USD | 4363.12% |
| AlloVir, Inc. | -190.14 Million USD | -491.446% |
| Novavax, Inc. | -487.39 Million USD | -130.742% |
| Aptorum Group Limited | -9.59 Million USD | -11615.922% |
| Ardelyx, Inc. | -55.35 Million USD | -1931.671% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -540.177% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -40771.463% |
| Vaxcyte, Inc. | -464.88 Million USD | -141.912% |
| Precigen, Inc. | -89.22 Million USD | -1160.407% |
| Pharming Group N.V. | 9.87 Million USD | 11486.16% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -607.085% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -4840.739% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -6522.761% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -381.638% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -6157.068% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -4564.133% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -4564.133% |
| Bicycle Therapeutics plc | -183.4 Million USD | -513.201% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -1186.343% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -3782.923% |
| Acelyrin, Inc. | -381.52 Million USD | -194.767% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 212691.871% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -3268.511% |
| Senti Biosciences, Inc. | -61.33 Million USD | -1733.525% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -901.399% |
| AbCellera Biologics Inc. | -192.15 Million USD | -485.253% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -3539.047% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -579.848% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -350246.106% |
| Chimerix, Inc. | -92.97 Million USD | -1109.597% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -3365.353% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -5478.704% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -2430.816% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -2299.836% |
| Elevation Oncology, Inc. | -41.46 Million USD | -2612.063% |
| Alkermes plc | 495.04 Million USD | 327.172% |
| Fortress Biotech, Inc. | -133.64 Million USD | -741.504% |
| Fortress Biotech, Inc. | -133.64 Million USD | -741.504% |
| Agenus Inc. | -145.92 Million USD | -670.683% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -1354.057% |
| Dyadic International, Inc. | -8.22 Million USD | -13565.209% |
| ImmuCell Corporation | -2.5 Million USD | -44811.199% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -386364.261% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -762.293% |
| Lantern Pharma Inc. | -15.78 Million USD | -7023.793% |
| Immix Biopharma, Inc. | -16.13 Million USD | -6869.731% |
| Incyte Corporation | 919.42 Million USD | 222.317% |
| IO Biotech, Inc. | -91.22 Million USD | -1132.748% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -1483.424% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -5547.794% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -1860.074% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -615.424% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -13294.605% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -1403.192% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | -195.974% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | -108.289% |
| NextCure, Inc. | -59.03 Million USD | -1804.861% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -11182.213% |
| Onconetix, Inc. | -36.7 Million USD | -2963.774% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 50418.166% |
| Opthea Limited | -200.01 Million USD | -462.253% |
| PDS Biotechnology Corporation | -40.08 Million USD | -2705.568% |
| PureTech Health plc | -11.62 Million USD | -9572.409% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -1332.753% |
| Seer, Inc. | -97.88 Million USD | -1048.91% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -8728038.153% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -4777.314% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -18286.374% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -3743.773% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -1812.929% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -4638.197% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -821.035% |
| ChromaDex Corporation | -3.89 Million USD | -28780.611% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -16236.592% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -899.352% |
| CRISPR Therapeutics AG | -202.7 Million USD | -454.813% |
| Precision BioSciences, Inc. | -32.04 Million USD | -3409.803% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -552.974% |
| Innoviva, Inc. | 248.96 Million USD | 551.724% |
| Summit Therapeutics Inc. | 1 Million USD | 112448.751% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -1708.143% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -1620.509% |
| ESSA Pharma Inc. | -26.45 Million USD | -4150.984% |
| GlycoMimetics, Inc. | -39.12 Million USD | -2774.626% |
| GT Biopharma, Inc. | 5.97 Million USD | 18909.349% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -444.097% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 1395.456% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -2095.691% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -11274.753% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -375.277% |
| Aptose Biosciences Inc. | -52.26 Million USD | -2051.624% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -943.787% |
| Soligenix, Inc. | -7.85 Million USD | -14221.055% |
| Century Therapeutics, Inc. | -121.2 Million USD | -827.836% |
| Kura Oncology, Inc. | -164.95 Million USD | -581.768% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -1304.044% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -11050.218% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -117323.536% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -25999.118% |
| Autolus Therapeutics plc | -156.77 Million USD | -617.364% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -1228.432% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -1529.847% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -5541.673% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -494.174% |
| GRI Bio, Inc. | -10.89 Million USD | -10219.426% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -24804.384% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -818.005% |
| IGM Biosciences, Inc. | -253.35 Million USD | -343.882% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -983.524% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -2849.164% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -7235.58% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -7043.452% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -1878.382% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -950.028% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -322.791% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -479.879% |
| Verastem, Inc. | -83.16 Million USD | -1252.249% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -2123.782% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -610.753% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -885.731% |
| Histogen Inc. | -10.5 Million USD | -10607.522% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -7775.588% |
| Surrozen, Inc. | -41.13 Million USD | -2634.218% |
| Organovo Holdings, Inc. | -14.8 Million USD | -7495.644% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 35067483.848% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -1815.432% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -2092.481% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -5121.278% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -13387.771% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -577.206% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -2183.082% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -4553.691% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -7369.997% |
| Apollomics, Inc. | -171.74 Million USD | -554.807% |
| Amarin Corporation plc | -50.9 Million USD | -2109.385% |
| Mesoblast Limited | -61.33 Million USD | -1733.675% |
| Turnstone Biologics Corp. | -56.23 Million USD | -1899.877% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -685.337% |
| Synaptogenix, Inc. | -8.3 Million USD | -13437.286% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -7231.71% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -1683.766% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -23371.126% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 262223.257% |
| Exelixis, Inc. | 196.6 Million USD | 672.024% |
| Better Therapeutics, Inc. | -38.26 Million USD | -2839.237% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -695.29% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | -127.097% |
| NLS Pharmaceutics AG | -11.79 Million USD | -9434.112% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 455010.281% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -3711.465% |
| Gritstone bio, Inc. | -126.86 Million USD | -786.477% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -1630.57% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -28015.655% |
| Avid Bioservices, Inc. | -11.48 Million USD | -9695.41% |
| Insmed Incorporated | -654.73 Million USD | -71.765% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -49888.954% |
| MediWound Ltd. | -4.89 Million USD | -22884.079% |
| OmniAb, Inc. | -49.73 Million USD | -2161.388% |
| Alector, Inc. | -142.89 Million USD | -687.036% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -1216.351% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -2056.576% |
| Zai Lab Limited | -366.57 Million USD | -206.79% |
| Revance Therapeutics, Inc. | -290.63 Million USD | -286.947% |
| Aura Biosciences, Inc. | -83.69 Million USD | -1243.685% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -399.275% |
| Immunic, Inc. | -99.11 Million USD | -1034.687% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -754.113% |
| Veracyte, Inc. | -49.4 Million USD | -2176.126% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -15820.47% |
| FibroGen, Inc. | -261.4 Million USD | -330.218% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -9994.345% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -15962.824% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -5908.543% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 177.59% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -4323.771% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 2919.281% |
| TG Therapeutics, Inc. | 26.1 Million USD | 4408.854% |
| Galecto, Inc. | -37.51 Million USD | -2897.444% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -2839.007% |
| Fortrea Holdings Inc. | 167.3 Million USD | 772.212% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -737.512% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -3872.346% |
| XBiotech Inc. | -35.76 Million USD | -3044.358% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -1630.57% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -1623.542% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -976.646% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -4280.691% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -2651.88% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | -117.756% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -1907.481% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -2006306.665% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -866.7% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -4972.772% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -378.428% |
| NexImmune, Inc. | -28.16 Million USD | -3892.582% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -20252.932% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -9436.848% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 124.163% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -4328.997% |
| Scopus BioPharma Inc. | -11.71 Million USD | -9501.269% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -793.641% |
| Ainos, Inc. | -8.77 Million USD | -12718.858% |
| Pluri Inc. | -20.22 Million USD | -5460.499% |
| Prothena Corporation plc | -190.1 Million USD | -491.564% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -777.245% |
| Celularity Inc. | -183.94 Million USD | -511.381% |
| Rallybio Corporation | -72.37 Million USD | -1453.91% |
| Cue Biopharma, Inc. | -46.05 Million USD | -2342.046% |
| MeiraGTx Holdings plc | -57.05 Million USD | -1871.203% |
| Omeros Corporation | -163.61 Million USD | -587.373% |
| Humacyte, Inc. | -96.45 Million USD | -1065.907% |
| Immunocore Holdings plc | -59.64 Million USD | -1785.381% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -5705.343% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -4515.682% |
| Blueprint Medicines Corporation | -474.61 Million USD | -136.954% |
| CalciMedica, Inc. | -34.18 Million USD | -3189.394% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -1435.641% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -796.126% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -567.619% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -345.585% |
| Pulmatrix, Inc. | -12.64 Million USD | -8793.018% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -3311.427% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -1171.221% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | -122.117% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -1011.111% |
| Cytokinetics, Incorporated | -456.68 Million USD | -146.256% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -3269.823% |
| Nutriband Inc. | -5.12 Million USD | -21857.438% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -2498.935% |
| Vor Biopharma Inc. | -114.37 Million USD | -883.301% |
| Roivant Sciences Ltd. | -996.51 Million USD | -12.854% |
| Evogene Ltd. | -23.2 Million USD | -4746.626% |
| ProKidney Corp. | -147.66 Million USD | -661.576% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -1642.637% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -734224.743% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | -98.881% |
| CorMedix Inc. | -48.88 Million USD | -2200.428% |
| BioLineRx Ltd. | -57.06 Million USD | -1870.893% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -906.291% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -556638.119% |
| Atai Life Sciences N.V. | -36.31 Million USD | -2997.163% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -1314.303% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -1283.064% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -308.203% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -3558.461% |
| MediciNova, Inc. | -9.87 Million USD | -11282.737% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -792.967% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -73394.332% |
| GeoVax Labs, Inc. | -26.66 Million USD | -4116.959% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -399.847% |
| Biomea Fusion, Inc. | -124.62 Million USD | -802.432% |
| PTC Therapeutics, Inc. | -330.34 Million USD | -240.44% |
| Mereo BioPharma Group plc | -26.05 Million USD | -4216.131% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -490.846% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -389.085% |
| Absci Corporation | -95.45 Million USD | -1078.134% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -3645.582% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -949.881% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -381.682% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -4820.634% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -441.105% |
| Allakos Inc. | -189.91 Million USD | -492.165% |
| Imunon, Inc. | -19.87 Million USD | -5557.487% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -936.584% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 1138.192% |
| BioAtla, Inc. | -122.24 Million USD | -819.995% |
| NLS Pharmaceutics AG | -11.79 Million USD | -9434.112% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -7035.404% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | -274.505% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -2613.371% |
| XOMA Corporation | -39.36 Million USD | -2757.098% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -1033.064% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -855.895% |
| aTyr Pharma, Inc. | -52.17 Million USD | -2055.336% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -1241.778% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -656.646% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -379.445% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -8137.098% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -13883.699% |
| Akari Therapeutics, Plc | -16.8 Million USD | -6593.316% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 596059.323% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 348.837% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -17503.334% |
| UroGen Pharma Ltd. | -63.83 Million USD | -1661.857% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -1555.91% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -15384.086% |
| Orgenesis Inc. | -60.71 Million USD | -1752.187% |
| Entera Bio Ltd. | -8.8 Million USD | -12673.864% |
| GH Research PLC | -41.15 Million USD | -2632.756% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -4306.956% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -1267.591% |
| Xencor, Inc. | -125.87 Million USD | -793.442% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -78734.597% |
| Replimune Group, Inc. | -230.19 Million USD | -388.541% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -5479.087% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -10177.929% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -17503.334% |
| Portage Biotech Inc. | -18.19 Million USD | -6079.521% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -73394.332% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -975.318% |
| OncoCyte Corporation | -23.12 Million USD | -4763.603% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -9851.991% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -9716.067% |
| Purple Biotech Ltd. | -22.22 Million USD | -4960.117% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -17444.633% |
| scPharmaceuticals Inc. | -46.06 Million USD | -2341.569% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -6214.605% |
| HilleVax, Inc. | -132.46 Million USD | -748.981% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -10476.611% |
| Tharimmune, Inc. | -9.3 Million USD | -11989.226% |
| Genprex, Inc. | -31.06 Million USD | -3520.703% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -499.709% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -3486.818% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -147100.393% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 745349.298% |
| OKYO Pharma Limited | -15.74 Thousand USD | -7142160.161% |
| Savara Inc. | -59.13 Million USD | -1801.833% |
| Curis, Inc. | -45.13 Million USD | -2391.44% |
| Daré Bioscience, Inc. | -30.7 Million USD | -3563.047% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -7303.068% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -15595.897% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -4106.669% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -6798.946% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | -161.184% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -1144.865% |
| Erasca, Inc. | -121.31 Million USD | -827.055% |
| bluebird bio, Inc. | -167.16 Million USD | -572.771% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -24898.266% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 462.446% |
| DBV Technologies S.A. | -85.98 Million USD | -1207.961% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -24898.266% |
| Moderna, Inc. | -3.28 Billion USD | 65.744% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -2539.374% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -19811.668% |
| Molecular Templates, Inc. | 1.43 Million USD | 78744.126% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -1778.987% |
| Travere Therapeutics, Inc. | -326.24 Million USD | -244.713% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -720.351% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -2274.3% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -708.875% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -446.299% |
| MacroGenics, Inc. | 2.01 Million USD | 55856.619% |
| RenovoRx, Inc. | -11.39 Million USD | -9773.67% |
| Adicet Bio, Inc. | -136.53 Million USD | -723.68% |
| Prime Medicine, Inc. | -193.75 Million USD | -480.417% |
| Aditxt, Inc. | -25.45 Million USD | -4317.521% |
| Adagene Inc. | -14.95 Million USD | -7422.087% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -15284.349% |
| Quantum-Si incorporated | -91.8 Million USD | -1125.013% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 257.86% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 989.337% |
| SciSparc Ltd. | -5.28 Million USD | -21191.386% |
| Vericel Corporation | 2.86 Million USD | 39367.144% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -1181114.814% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -5084.587% |
| Generation Bio Co. | -133.3 Million USD | -743.669% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -1254.463% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -1207.338% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -394.478% |
| Invivyd, Inc. | -196.61 Million USD | -471.986% |
| Relay Therapeutics, Inc. | -374.15 Million USD | -200.575% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -12025.45% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 4241.603% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -10834.477% |
| 2seventy bio, Inc. | -206.41 Million USD | -444.822% |
| ADMA Biologics, Inc. | 5.12 Million USD | 22065.059% |
| Clene Inc. | -43.24 Million USD | -2500.798% |
| Capricor Therapeutics, Inc. | -23 Million USD | -4787.705% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -2219.886% |
| GeoVax Labs, Inc. | -26.66 Million USD | -4116.959% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | -275.413% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -2961.886% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 4870.759% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 23003.312% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -3362.259% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -609.964% |
| Vir Biotechnology, Inc. | -684.3 Million USD | -64.344% |
| Evaxion Biotech A/S | -21.4 Million USD | -5154.455% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -1593.309% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -416.661% |
| Trevena, Inc. | -35.28 Million USD | -3086.95% |
| Surrozen, Inc. | -41.13 Million USD | -2634.218% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -1312.97% |
| Cingulate Inc. | -22.95 Million USD | -4799.832% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -14973.194% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -2916.418% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -13570.803% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -999.692% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -1558.058% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -1826.627% |
| Clearmind Medicine Inc. | -8.71 Million USD | -12810.74% |
| Kronos Bio, Inc. | -121.83 Million USD | -823.099% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -1412.753% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -45963.92% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -1015.387% |
| Statera Biopharma, Inc. | 38.93 Million USD | 2988.435% |
| ImmunityBio, Inc. | -436.18 Million USD | -157.831% |
| Korro Bio, Inc. | -80.9 Million USD | -1290.056% |
| Kineta, Inc. | -15.71 Million USD | -7056.746% |
| BioVie Inc. | -31.95 Million USD | -3419.886% |
| Codexis, Inc. | -49.28 Million USD | -2181.945% |
| Celularity Inc. | -183.94 Million USD | -511.381% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -407.702% |
| Celcuity Inc. | -58.3 Million USD | -1828.677% |
| Virax Biolabs Group Limited | -6.6 Million USD | -16915.986% |
| Cibus, Inc. | -314.58 Million USD | -257.49% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -3233.86% |
| IN8bio, Inc. | -28.5 Million USD | -3845.45% |
| Kodiak Sciences Inc. | -259.02 Million USD | -334.174% |
| Annexon, Inc. | -141.57 Million USD | -694.357% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -898.775% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -1651.84% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -3922.933% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -388.94% |
| Eyenovia, Inc. | -24.1 Million USD | -4565.267% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 2611.189% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -347002.16% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -1423.781% |
| Arcellx, Inc. | -64.14 Million USD | -1653.233% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -2398.358% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -810.793% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -3541.639% |
| Moolec Science SA | -52.07 Million USD | -2059.576% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -2079.225% |
| Geron Corporation | -174.78 Million USD | -543.436% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -2682.52% |
| Royalty Pharma plc | 1.88 Billion USD | 159.589% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -840.365% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -11961.136% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -5322.228% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -577.15% |
| Humacyte, Inc. | -96.45 Million USD | -1065.907% |
| Structure Therapeutics Inc. | -102.45 Million USD | -997.621% |
| 89bio, Inc. | -134.46 Million USD | -736.372% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -1325.814% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 27854.467% |
| Genelux Corporation | -24.16 Million USD | -4553.884% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -3227.251% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -587.987% |
| Notable Labs, Ltd. | -14.4 Million USD | -7709.799% |
| Liquidia Corporation | -70.05 Million USD | -1505.417% |
| Mustang Bio, Inc. | -48.06 Million USD | -2239.869% |
| Immunovant, Inc. | -269.97 Million USD | -316.557% |
| Quantum-Si incorporated | -91.8 Million USD | -1125.013% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -1484.272% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -5724.586% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -1002.43% |
| Acasti Pharma Inc. | -11.3 Million USD | -9851.429% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -4953.695% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -7235.58% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -434.224% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -26235.379% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -6981.933% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -3808.156% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -2937.027% |
| PepGen Inc. | -83.58 Million USD | -1245.518% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -3711.724% |
| United Therapeutics Corporation | 1.38 Billion USD | 181.094% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -4811.609% |
| Solid Biosciences Inc. | -93.43 Million USD | -1103.642% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -23468.173% |
| Immuneering Corporation | -58.06 Million USD | -1836.954% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 35067483.848% |
| Silo Pharma, Inc. | -3.62 Million USD | -30913.365% |
| Belite Bio, Inc | -31.52 Million USD | -3466.91% |
| XOMA Corporation | -39.36 Million USD | -2757.098% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -1567.4% |
| Bionomics Limited | -9.83 Million USD | -11332.465% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -1239.062% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -3149.757% |
| uniQure N.V. | -253.1 Million USD | -344.335% |
| Cassava Sciences, Inc. | -95.68 Million USD | -1075.302% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -15284.349% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -768.399% |
| Forte Biosciences, Inc. | -32.47 Million USD | -3362.792% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -13869.502% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -3885.297% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -347002.16% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -9994.345% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -6972.58% |
| Altimmune, Inc. | -87.93 Million USD | -1178.912% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -1121.354% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -3149.757% |
| Compugen Ltd. | -12.51 Million USD | -8885.387% |
| Peak Bio, Inc. | -1356.23 USD | -82921749.539% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -2214.11% |
| Benitec Biopharma Inc. | -22.49 Million USD | -4900.494% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -364.134% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -3840.059% |
| Zura Bio Limited | -60.56 Million USD | -1756.927% |
| PolyPid Ltd. | -20.26 Million USD | -5450.072% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -7103.042% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -3840.059% |
| Instil Bio, Inc. | -146.12 Million USD | -669.638% |
| argenx SE | -216.02 Million USD | -420.598% |
| Immunome, Inc. | -28.27 Million USD | -3877.967% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -2220.077% |
| Verona Pharma plc | -52.46 Million USD | -2043.44% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -1086.649% |
| Shattuck Labs, Inc. | -87.61 Million USD | -1183.583% |
| CervoMed Inc. | -2.17 Million USD | -51680.674% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -819.972% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -8760.088% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -2234.477% |
| Moolec Science SA | -52.07 Million USD | -2059.576% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -6461.331% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -762.491% |
| AnaptysBio, Inc. | -143.16 Million USD | -685.54% |
| Design Therapeutics, Inc. | -66.32 Million USD | -1595.606% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -1288.632% |
| NeurAxis, Inc. | -6.66 Million USD | -16774.662% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -2879.102% |
| Lumos Pharma, Inc. | -36.57 Million USD | -2975.228% |
| Achilles Therapeutics plc | -70.44 Million USD | -1496.506% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -1086.649% |
| 180 Life Sciences Corp. | -22.13 Million USD | -4980.915% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 19392.56% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -45963.92% |
| Nutriband Inc. | -5.12 Million USD | -21857.438% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -924.721% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -1928.812% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -2124.75% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -1622.829% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -1978.382% |
| Palisade Bio, Inc. | -12.28 Million USD | -9057.324% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -2378.427% |
| Beam Therapeutics Inc. | -156.47 Million USD | -618.725% |
| Neurogene Inc. | -52.28 Million USD | -2050.884% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -723.951% |
| AEON Biopharma, Inc. | -48.36 Million USD | -2225.45% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -1109.025% |
| Sesen Bio, Inc. | -50.84 Million USD | -2112.059% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -1272.615% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -9006.145% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | -163.109% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -969.052% |
| Athira Pharma, Inc. | -116.7 Million USD | -863.652% |
| Vaccinex, Inc. | -19.74 Million USD | -5594.81% |
| HCW Biologics Inc. | -23.57 Million USD | -4670.141% |
| XOMA Corporation | -39.36 Million USD | -2757.098% |
| Nektar Therapeutics | -243.1 Million USD | -362.599% |
| Arvinas, Inc. | -394.8 Million USD | -184.856% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 596059.323% |
| Merus N.V. | -149.2 Million USD | -653.725% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -1102.921% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -3497.604% |
| Rezolute, Inc. | -68.42 Million USD | -1543.615% |
| Clene Inc. | -43.24 Million USD | -2500.798% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -7192.161% |
| BeyondSpring Inc. | -21.54 Million USD | -5121.035% |
| Synlogic, Inc. | -55.16 Million USD | -1938.779% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -9207.382% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -10467.666% |
| Peak Bio, Inc. | -1356.23 USD | -82921749.539% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -3364.072% |
| Krystal Biotech, Inc. | 17.9 Million USD | 6381.339% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -849.656% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | -229.464% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -24313.928% |
| MannKind Corporation | 15.12 Million USD | 7533.479% |
| Ikena Oncology, Inc. | -74.39 Million USD | -1411.635% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -8830.445% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 5632.597% |
| Gossamer Bio, Inc. | -172.15 Million USD | -553.266% |
| CohBar, Inc. | -12.06 Million USD | -9220.682% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -4308.683% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -3645.582% |
| Legend Biotech Corporation | -477.87 Million USD | -135.337% |
| Mural Oncology plc | -192.72 Million USD | -483.547% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -886.034% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -6865.576% |
| Disc Medicine, Inc. | -91.02 Million USD | -1135.497% |
| Champions Oncology, Inc. | -5.05 Million USD | -22151.899% |
| REGENXBIO Inc. | -239.46 Million USD | -369.637% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -10392.549% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -1917.022% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -2800.854% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -896.943% |
| Vaxart, Inc. | -74.72 Million USD | -1405.04% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -3094.165% |
| Cellectis S.A. | -98.09 Million USD | -1046.451% |
| Longeveron Inc. | -20.06 Million USD | -5506.236% |
| Repare Therapeutics Inc. | -114.27 Million USD | -884.144% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | -156.061% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -1403.249% |
| Revolution Medicines, Inc. | -430.58 Million USD | -161.184% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -17782.191% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -3552.639% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -1407.724% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 23037.202% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -10156.37% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 124.42% |
| Denali Therapeutics Inc. | -179.97 Million USD | -524.878% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -1181114.814% |
| Veru Inc. | -89.97 Million USD | -1149.907% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -4084.132% |
| Cingulate Inc. | -22.95 Million USD | -4799.832% |
| Passage Bio, Inc. | -98.34 Million USD | -1043.583% |
| Context Therapeutics Inc. | -25.06 Million USD | -4387.571% |
| Exicure, Inc. | -15.53 Million USD | -7137.345% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -445.758% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -2941.462% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -18761.097% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -567.568% |
| Nuvalent, Inc. | -149.49 Million USD | -652.288% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -13728.746% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -1209.301% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -3626.592% |
| OmniAb, Inc. | -49.73 Million USD | -2161.388% |
| Anew Medical, Inc. | -1.3 Million USD | -86352.677% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -8995.851% |
| Lipocine Inc. | -16.32 Million USD | -6789.873% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -1586.832% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -1413.547% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -2849.164% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -2782.583% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -4969.698% |
| Sage Therapeutics, Inc. | -545.07 Million USD | -106.324% |
| Ocugen, Inc. | -64.82 Million USD | -1634.788% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -1114.876% |
| Q32 Bio Inc. | -86.5 Million USD | -1200.098% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -6543.888% |
| Alumis Inc. Common Stock | -156.89 Million USD | -616.815% |
| Equillium, Inc. | -12.13 Million USD | -9165.208% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -1823.333% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -14129.55% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -5862.635% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -2308.573% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -957.512% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -6187.453% |
| Dominari Holdings Inc. | -22.44 Million USD | -4911.635% |
| Edesa Biotech, Inc. | -8.19 Million USD | -13631.276% |
| vTv Therapeutics Inc. | -25.41 Million USD | -4325.512% |
| Bio-Techne Corporation | 326.66 Million USD | 444.273% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | -192.21% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 619.717% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -757.775% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -2904.491% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -644.278% |
| Nkarta, Inc. | -120.48 Million USD | -833.434% |
| BioCardia, Inc. | -11.56 Million USD | -9628.469% |
| Iterum Therapeutics plc | -34.58 Million USD | -3152.201% |